Orexin 1 inhibitors for addictive disorders

  • Product Overview: Best in class, selective Orexin 1 inhibitors for stress-related addictive disorders
  • Primary Indications(s): Nicotine addiction
  • Secondary Indication: Panic Disorders, Binge eating (BED) and cocaine dependence
  • Core Differentiators: Highly potent compounds with high selectivity for Orexin-1 inhibition over Orexin-2
  • Development Stage: Lead Optimisation
  • Available for license collaboration